Search results for "Infectious Diseases"


 
Results 11 - 20 of about 297 for "Infectious Diseases".
Sort by: Relevance | Newest | Oldest

Modeling study finds RSV vaccines cost-effective for older U.S. adults

Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023

RSV vaccines new tool for physicians

The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023

CDC publishes guidance on testing for flu, COVID-19

Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023

Specialty groups offer guide on which lab tests are best for diagnosing infectious diseases

The Infectious Diseases Society of America and the American Society for Microbiology have published a guide to help physicians determine which tests are most useful in diagnosing infectious diseases.
https://immattersacp.org/weekly/archives/2013/07/23/5.htm
23 Jul 2013

Coadministration of zoster vaccine, COVID-19 booster appears safe, effective

An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2023

CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants

The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023

IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections

New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
https://immattersacp.org/weekly/archives/2020/09/15/4.htm
15 Sep 2020

CDC study shows uptick in C. auris infections in recent years

Cases and transmission of Candida auris have continued to rise since the multidrug-resistant fungus was first reported in the U.S. in 2016. Reports of cases to the CDC rose by 44% in 2019 and 95% in 2021.
https://immattersacp.org/weekly/archives/2023/03/21/1.htm
21 Mar 2023

Monkeypox: 5 key points

An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next